Bunge Limited (BG) Misses Q2 EPS by 1c, Beats on Revenues
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Bunge Limited (BG) Granted Approval by U.S. FDA To Claim Soybean Oil as Heart Healthy
July 31, 2017 12:26 PM EDTBunge North America, the North American arm of Bunge Limited (NYSE: BG), is pleased to announce that the U.S. Food and Drug Administration (FDA) approved its petition for a qualified health claim linking consumption of soybean oil to reduced risk of coronary heart disease. Bunge independently filed a petition with the FDA that included a summary of human clinical studies from top nutrition researchers demonstrating the heart health potential of soybean oilAmerica's most commonly used ingredient and top dietary source of omega-3 fats. Upon review, the FDA will allow companies to communicate... More
